Movers and shakers in the science industry for March 2021.
This book is much more than a comprehensive review of modern virology. It is a memoir of the author’s long association with this science. The author has been at the forefront of virus research for the past 50 years and has strong views on the evolution of viruses – what she calls paleovirology, the origin of gene sequences.
This book, with its wide array of fascinating examples of adhesion, should appeal to a wide scientific readership.
Karl H. Lauri explains how ERP/MRP gives smaller pharma and biotech suppliers the backbone necessary to give the resilience required today. Read the feature in full in C&I Magazine.
Forests have always been vulnerable to insect pests, fire and strong winds, but climate change can enhance these threats. A new study has quantified forest vulnerability to disturbances using satellite data on disturbance of forests, forest type, cover and conditions, climate and other factors (Nature Commun., doi: 10.1038/s41467-021-21399-7). Read more in C&I Magazine.
Smoking cessation drug cytisine reduces the loss of a type of nerve cell in the brains of female mice. The findings provide evidence for the use of the drug to treat Parkinson’s disease (PD) or stop its progression in women, say researchers. Read more in C&I Magazine.
A compound in tree resin has been attached to a nanocellulose film and shown to kill methicillin-resistant Staph. aureus (MRSA) on contact. The combination was shown to prevent MRSA bacteria from colonising a surface mimicking the environment of chronic wounds (ACS Appl. Bio Mater., 2020, 3, 4095). Read more in C&I Magazine.
A new test that detects the magnetic properties of malaria-infected blood appears to work well in the field, producing results quickly and relatively inexpensively.
A therapy based on CRISPR gene editing technology appears to stop replication of viruses responsible for both flu and Covid-19. The therapy could be delivered directly to the lungs using a nebuliser, making it easy for patients to use at home. Read more in C&I Magazine.
A database of cancer vulnerability could one day allow physicians to look up personalised treatments best suited to patients based on their individual cancer genes. However, scientists working on the project have called for worldwide cooperation (Boehm et al, Nature, 2021, 589, 514) to accelerate progress, they reported at the virtual AAAS meeting in February 2021.